Miriam Galbusera

Science And Technology Park Kilometro Rosso
Bergamo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis.

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis.

Journal: Frontiers in immunology

Published: November 19, 2025

Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy.

Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy.

Journal: Kidney international reports

Published: June 11, 2024

An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome.

An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome.

Journal: Frontiers in immunology

Published: November 30, 2022

The complement alternative pathway and hemostasis.

The complement alternative pathway and hemostasis.

Journal: Immunological reviews

Published: October 22, 2022

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.

Journal: Frontiers in immunology

Published: December 01, 2021

Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.

Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.

Journal: PloS one

Published: June 11, 2021

Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.

Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.

Journal: Frontiers in immunology

Published: May 19, 2021

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.

Journal: Blood advances

Published: May 11, 2021

Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant.

Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant.

Journal: Frontiers in medicine

Published: July 02, 2020

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: March 12, 2018

Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis.

Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: June 27, 2016

Liver transplantation for aHUS: still needed in the eculizumab era?

Liver transplantation for aHUS: still needed in the eculizumab era?

Journal: Pediatric nephrology (Berlin, Germany)

Published: August 27, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026